The recent merger between two of the nation’s largest health insurance companies has prompted antitrust and anti-competition concerns from other sectors of the health care industry. The American Hospital Association recently sent a letter to the U.S. Department of Justice, urging federal regulators to carefully consider every detail of the merger. Many fear the spate of recent mergers between four of the nation’s top insurance companies could end up hurting patients by driving up costs, limiting access to treatment, and hurting medical innovation. Aimed Alliance strongly believes all Americans should be able to afford quality care that meets their health care needs. Federal regulators must ensure that any outcome does not result in patient discrimination or even greater difficulty in accessing care. To read the full article from Modern Healthcare, click here.
Last Updated on May 7, 2020 by Aimed Alliance
